NCT00392327 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
- id
- FG000
- title
- Regimen A (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
- id
- FG001
- title
- Regimen B (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
- id
- FG002
- title
- Regimen C (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
- id
- FG003
- title
- Regimen D (Medulloblastoma Patients)
- description
- SPNET patients who received regimen A (no carboplatin / no isotretinoin)
- id
- FG004
- title
- Regimen A (SPNET Patients)
- description
- SPNET patients who received regimen B (carboplatin / no isotretinoin)
- id
- FG005
- title
- Regimen B (SPNET Patients)
- description
- SPNET patients who received regimen C (no carboplatin / isotretinoin)
- id
- FG006
- title
- Regimen C (SPNET Patients)
- description
- SPNET patients who received regimen D (carboplatin / isotretinoin)
- id
- FG007
- title
- Regimen D (SPNET Patients)
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 3
- group Id
- FG007
- num Subjects
- 3
- type
- Lack of Efficacy
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 3
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 87
- group Id
- FG001
- num Subjects
- 93
- group Id
- FG002
- num Subjects
- 56
- group Id
- FG003
- num Subjects
- 58
- group Id
- FG004
- num Subjects
- 23
- group Id
- FG005
- num Subjects
- 19
- group Id
- FG006
- num Subjects
- 21
- group Id
- FG007
- num Subjects
- 22
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 72
- group Id
- FG001
- num Subjects
- 74
- group Id
- FG002
- num Subjects
- 36
- group Id
- FG003
- num Subjects
- 42
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 12
- group Id
- FG007
- num Subjects
- 11
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 20
- group Id
- FG003
- num Subjects
- 16
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 5
- group Id
- FG006
- num Subjects
- 9
- group Id
- FG007
- num Subjects
- 11
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Participants received standard therapy consisting of surgery, radiation and chemotherapy. A subset of patients was randomly assigned to receive carboplatin. A second randomization was used to randomly assign patients to receive isotretinoin. Of note, the isotretinoin randomization was stopped early due to futility.
- recruitment Details
- Patients (Pts) 3-21 yrs were recruited at COG institutions.The first pt was enrolled 5/23/2007, and the last pt was enrolled 4/9/2018.The study was initially open to medulloblastoma and supratentorial primitive neuroectodermal tumor (SPNET) pts, but closed for SPNET pts as of amendment #2.All pts were off treatment at the time of results reporting.
Complete source fields
- groups
- description
- Medulloblastoma patients who received regimen A (no carboplatin / no isotretinoin)
- id
- FG000
- title
- Regimen A (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen B (carboplatin / no isotretinoin)
- id
- FG001
- title
- Regimen B (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen C (no carboplatin / isotretinoin)
- id
- FG002
- title
- Regimen C (Medulloblastoma Patients)
- description
- Medulloblastoma patients who received regimen D (carboplatin / isotretinoin)
- id
- FG003
- title
- Regimen D (Medulloblastoma Patients)
- description
- SPNET patients who received regimen A (no carboplatin / no isotretinoin)
- id
- FG004
- title
- Regimen A (SPNET Patients)
- description
- SPNET patients who received regimen B (carboplatin / no isotretinoin)
- id
- FG005
- title
- Regimen B (SPNET Patients)
- description
- SPNET patients who received regimen C (no carboplatin / isotretinoin)
- id
- FG006
- title
- Regimen C (SPNET Patients)
- description
- SPNET patients who received regimen D (carboplatin / isotretinoin)
- id
- FG007
- title
- Regimen D (SPNET Patients)
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 1
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 8
- group Id
- FG001
- num Subjects
- 8
- group Id
- FG002
- num Subjects
- 9
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 3
- group Id
- FG007
- num Subjects
- 3
- type
- Lack of Efficacy
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 5
- group Id
- FG002
- num Subjects
- 2
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 5
- group Id
- FG007
- num Subjects
- 3
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 1
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 2
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 6
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 1
- group Id
- FG007
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 4
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 2
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- Ineligible
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 87
- group Id
- FG001
- num Subjects
- 93
- group Id
- FG002
- num Subjects
- 56
- group Id
- FG003
- num Subjects
- 58
- group Id
- FG004
- num Subjects
- 23
- group Id
- FG005
- num Subjects
- 19
- group Id
- FG006
- num Subjects
- 21
- group Id
- FG007
- num Subjects
- 22
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 72
- group Id
- FG001
- num Subjects
- 74
- group Id
- FG002
- num Subjects
- 36
- group Id
- FG003
- num Subjects
- 42
- group Id
- FG004
- num Subjects
- 20
- group Id
- FG005
- num Subjects
- 14
- group Id
- FG006
- num Subjects
- 12
- group Id
- FG007
- num Subjects
- 11
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 15
- group Id
- FG001
- num Subjects
- 19
- group Id
- FG002
- num Subjects
- 20
- group Id
- FG003
- num Subjects
- 16
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 5
- group Id
- FG006
- num Subjects
- 9
- group Id
- FG007
- num Subjects
- 11
- type
- NOT COMPLETED
- title
- Overall Study
- pre Assignment Details
- Participants received standard therapy consisting of surgery, radiation and chemotherapy. A subset of patients was randomly assigned to receive carboplatin. A second randomization was used to randomly assign patients to receive isotretinoin. Of note, the isotretinoin randomization was stopped early due to futility.
- recruitment Details
- Patients (Pts) 3-21 yrs were recruited at COG institutions.The first pt was enrolled 5/23/2007, and the last pt was enrolled 4/9/2018.The study was initially open to medulloblastoma and supratentorial primitive neuroectodermal tumor (SPNET) pts, but closed for SPNET pts as of amendment #2.All pts were off treatment at the time of results reporting.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle